← Insider trading tracker

Every insider trade Chris Koopmans has disclosed

President and COO · Marvell Technology, Inc. (MRVL)

Key points

  • Chris Koopmans has disclosed 8 Form 4 transactions between Sep 25, 2025 and Oct 1, 2026: 7 sales worth $14.1M and 1 open-market buy worth $531K.
  • Of the 7 sales, 7 were under a pre-scheduled 10b5-1 plan, leaving 0 discretionary sales worth $0.
  • The largest single transaction is a sell of 10,000 shares of MRVL worth $2.8M, filed Jul 1, 2026.
  • Insider selling is not on its own a bearish signal — plans, taxes and diversification all drive sales. This page is a record of disclosed trades, not investment advice.
  • The most recent filing on record was made Oct 1, 2026. Insiders file within two business days of a trade.

This is the public record of open-market stock transactions Chris Koopmans has reported to the SEC on Form 4 as President and COO of Marvell Technology, Inc. (MRVL). Every figure below is the reported share count multiplied by the reported price, so the dollar amounts are exact disclosed values rather than estimates. It is a record of what has been filed, not a portfolio or a recommendation, and insider selling in particular is routine and rarely a signal on its own.

Buying vs selling at a glance

MeasureOpen-market buysSales
Transactions17
Total disclosed value$531K$14.1M
Discretionary (own call)10 ($0)

Most of Chris Koopmans's sales were pre-scheduled or tax-related rather than discretionary, which further weakens any read of them as a market call.

Every disclosed transaction

All 8 disclosed transactions, newest filing first.

StockActionSharesPriceValueTradedFiled
MRVL Marvell Technology, Inc.▼ Sell 10b5-1 plan10,000$262.05$2.6MOct 1, 2026Oct 1, 2026
MRVL Marvell Technology, Inc.▼ Sell 10b5-1 plan10,000$203.27$2.0MSep 1, 2026Sep 2, 2026
MRVL Marvell Technology, Inc.▼ Sell 10b5-1 plan10,000$180.50$1.8MAug 3, 2026Aug 3, 2026
MRVL Marvell Technology, Inc.▼ Sell 10b5-1 plan10,000$281.92$2.8MJul 1, 2026Jul 1, 2026
MRVL Marvell Technology, Inc.▼ Sell 10b5-1 plan10,000$205.87$2.1MJun 1, 2026Jun 1, 2026
MRVL Marvell Technology, Inc.▼ Sell 10b5-1 plan10,000$162.76$1.6MMay 1, 2026May 4, 2026
MRVL Marvell Technology, Inc.▼ Sell 10b5-1 plan10,000$110.24$1.1MApr 6, 2026Apr 6, 2026
MRVL Marvell Technology, Inc.▲ Buy own call6,800$78.03$531KSep 25, 2025Sep 25, 2025

Questions about this record

How many shares has Chris Koopmans bought and sold?

Chris Koopmans has disclosed 8 Form 4 transactions in the record we track, from Sep 25, 2025 to Oct 1, 2026: 7 sales worth $14,066,100 and 1 open-market purchase worth $530,604. Each figure is the reported share count multiplied by the reported price, so these are exact disclosed amounts, not estimates.

Is Chris Koopmans selling a bearish signal?

Not on its own. Insiders sell for many reasons that have nothing to do with a view on the stock — diversification, taxes, estate planning, or a pre-scheduled plan set up months earlier. Of the 7 sales on this record, 7 were made under a Rule 10b5-1 plan and 0 were automatic tax withholding on vesting shares, leaving 0 that were the insider's own discretionary decision (worth $0). Buying is the cleaner signal, because there is only one reason to buy. This page is a record, not a recommendation.

What is Chris Koopmans's role?

Chris Koopmans files as President and COO of Marvell Technology, Inc. (MRVL). That role is taken from the Form 4 filings themselves. A Form 4 is filed with the SEC within two business days of an insider buying or selling their own company's stock.

What was Chris Koopmans's largest single transaction?

The largest single transaction on record is a sell of 10,000 shares of MRVL at $281.92, worth $2,819,200, filed Jul 1, 2026.

How current is this record?

The most recent Form 4 here was filed Oct 1, 2026. Insiders have two business days to file after a trade, so this is close to real time, but it is a record of what has been disclosed, not a statement of what Chris Koopmans currently holds. Amounts are open-market and plan transactions reported on Form 4; grants and option exercises are not counted as buys.

Source: Form 4 filings submitted to the SEC, the same public documents behind our insider trading tracker. Figures are open-market and plan transactions only; grants and option exercises are not counted as buys. A disclosure is not evidence of a market view, and none of this is investment advice. See the full MRVL stock page for price, filings and coverage.